United States Biotechnology & Medical Research

Kezar Life Sciences Inc (KZR)

Track

The most recent insider trading activity at Kezar Life Sciences Inc. occurred on July 2, 2025, involving sales by the Chief Operating Officer and the SVP of Corporate Controller. These transactions follow a pattern of divestment observed over previous years. No insider buying activity has been recorded within the last three months.
Ticker: KZR Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Kezar Life Sciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 2 Jul 2025
Value US$998,421.84 | Price 205.23 | Shares 29,529 (+33.0%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-07-03 2025-07-02 S Sale
1.6
Schiller Mark C.

Chief Operating Officer

Officer
29,529 +33.0%
205.23
US$998,422 		29,529 +33.0% 205.23 US$998,422
2025-07-03 2025-07-02 S Sale
2.1
Chiang Pichi Luo

SVP, Corporate Controller

Officer
10,457 -14.3%
16.51
US$1,996,358 		10,457 -14.3% 16.51 US$1,996,358
2024-07-26 2024-07-02 S Sale
1.6
Schiller Mark C.

Chief Legal Officer

Officer
10,392 -7.6%
145.65
US$3,578,228 		10,392 -7.6% 145.65 US$3,578,228
2023-02-07 2023-02-06 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
40,000 -0.7%
6.88
US$275,320 		40,000 -0.7% 6.88 US$275,320
2023-02-07 2023-02-03 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
25,000 -0.5%
7.15
US$178,650 		25,000 -0.5% 7.15 US$178,650
2023-02-03 2023-02-02 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
50,000 -0.9%
7.19
US$359,500 		50,000 -0.9% 7.19 US$359,500
2023-02-03 2023-02-01 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
40,000 -0.7%
6.95
US$278,000 		40,000 -0.7% 6.95 US$278,000
2023-02-01 2023-01-31 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
30,000 -0.5%
7.08
US$212,400 		30,000 -0.5% 7.08 US$212,400
2023-02-01 2023-01-30 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
30,000 -0.5%
6.91
US$207,300 		30,000 -0.5% 6.91 US$207,300
2023-01-27 2023-01-25 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
50,000 -0.9%
6.85
US$342,500 		50,000 -0.9% 6.85 US$342,500
2023-01-25 2023-01-24 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
80,000 -1.4%
6.98
US$558,400 		80,000 -1.4% 6.98 US$558,400
2023-01-25 2023-01-23 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
80,000 -1.4%
6.81
US$544,800 		80,000 -1.4% 6.81 US$544,800
2023-01-19 2023-01-17 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
6,114 -0.1%
6.79
US$41,514 		6,114 -0.1% 6.79 US$41,514
2023-01-17 2023-01-13 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
1,971 -0.0%
7.15
US$14,093 		1,971 -0.0% 7.15 US$14,093
2023-01-17 2023-01-12 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
5,000 -0.1%
6.77
US$33,850 		5,000 -0.1% 6.77 US$33,850
2023-01-09 2023-01-06 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
3,000 -0.1%
6.89
US$20,670 		3,000 -0.1% 6.89 US$20,670
2023-01-09 2023-01-05 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
12,162 -0.2%
6.97
US$84,769 		12,162 -0.2% 6.97 US$84,769
2023-01-05 2023-01-04 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
30,000 -0.5%
7.17
US$215,100 		30,000 -0.5% 7.17 US$215,100
2023-01-05 2023-01-03 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
500 -0.0%
7.10
US$3,550 		500 -0.0% 7.10 US$3,550
2023-01-05 2022-12-29 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
25,000 -0.4%
7.10
US$177,500 		25,000 -0.4% 7.10 US$177,500
2022-10-05 2022-10-04 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
3,612 -0.1%
8.82
US$31,857 		3,612 -0.1% 8.82 US$31,857
2022-10-05 2022-10-03 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
28,700 -0.5%
8.78
US$251,957 		28,700 -0.5% 8.78 US$251,957
2022-03-22 2022-03-21 B Purchase
2.3
BERGER FRANKLIN M
Non-Executive Director
20,000 +2.3%
14.77
US$295,400 		20,000 +2.3% 14.77 US$295,400
2022-03-22 2022-03-18 B Purchase
2.3
BERGER FRANKLIN M
Non-Executive Director
45,000 +5.4%
17.00
US$765,000 		45,000 +5.4% 17.00 US$765,000
2022-03-22 2022-03-18 B Purchase
2.3
BERGER FRANKLIN M
Non-Executive Director
15,000 +1.9%
15.96
US$239,400 		15,000 +1.9% 15.96 US$239,400
2022-01-05 2022-01-03 PlS Planned sale
3.9
Kauffman Michael
Non-Executive Director
5,000 -7.3%
16.45
US$82,250 		5,000 -7.3% 16.45 US$82,250
2020-06-15 2020-06-11 B Purchase
0.8
Equal Talent Investments Ltd
Large shareholder
1,454,545 +30.3%
5.50
US$7,999,998 		1,454,545 +30.3% 5.50 US$7,999,998
2020-06-11 2020-06-11 B Purchase
2.3
BERGER FRANKLIN M
Non-Executive Director
100,000 +14.6%
5.50
US$550,000 		100,000 +14.6% 5.50 US$550,000
2020-02-06 2020-02-04 B Purchase
3.5
Morningside Venture Investments Ltd
Large shareholder
3,800,000 +164.6%
2.60
US$9,880,000 		3,800,000 +164.6% 2.60 US$9,880,000
2020-02-05 2020-02-04 PP Planned purchase
Kirk Christopher J.

President and CSO

Executive Director
38,461 +12.6%
2.60
US$99,999 		38,461 +12.6% 2.60 US$99,999
2020-02-05 2020-02-04 B Purchase
2.3
BERGER FRANKLIN M
Non-Executive Director
120,846 +21.5%
2.60
US$314,200 		120,846 +21.5% 2.60 US$314,200
2020-02-05 2020-02-04 B Purchase
1.7
Economides Vassiliki

SVP, Strategy & External Aff.

Officer
5,769 +320.3%
2.60
US$14,999 		5,769 +320.3% 2.60 US$14,999
2020-02-05 2020-02-04 B Purchase
0.8
Belsky Marc

CFO

Officer
15,384 +inf%
2.60
US$39,998 		15,384 +inf% 2.60 US$39,998
2020-02-05 2020-02-04 B Purchase
2.3
Fowler John Franklin

CEO

Executive Director
38,461 +inf%
2.60
US$99,999 		38,461 +inf% 2.60 US$99,999
2019-11-13 2019-11-13 B Purchase Belsky Marc

CFO

Officer
800 +66.7%
2.76
US$2,207 		800 +66.7% 2.76 US$2,207
2019-10-11 2019-10-10 B Purchase
2.3
Fowler John Franklin

CEO

Executive Director
1,000 +0.3%
3.24
US$3,235 		1,000 +0.3% 3.24 US$3,235
2019-08-21 2019-08-20 B Purchase Belsky Marc

CFO

Officer
200 +20.0%
4.42
US$884 		200 +20.0% 4.42 US$884
2019-08-21 2019-08-20 B Purchase Economides Vassiliki

SVP, Strategy & External Aff.

Officer
350 +24.1%
4.41
US$1,544 		350 +24.1% 4.41 US$1,544
2019-08-15 2019-08-13 B Purchase Kirk Christopher J.

President and CSO

Executive Director
5,000 +1.7%
4.61
US$23,040 		5,000 +1.7% 4.61 US$23,040
2019-08-14 2019-08-13 B Purchase Fowler John Franklin

CEO

Executive Director
2,000 +0.7%
4.66
US$9,310 		2,000 +0.7% 4.66 US$9,310
2019-08-12 2019-08-09 B Purchase Economides Vassiliki

SVP, Strategy & External Aff.

Officer
1,020 +236.7%
4.96
US$5,057 		1,020 +236.7% 4.96 US$5,057
2019-08-12 2019-08-09 B Purchase Belsky Marc

CFO

Officer
500 +100.0%
4.82
US$2,410 		500 +100.0% 4.82 US$2,410
2019-08-12 2019-08-09 PP Planned purchase Kirk Christopher J.

President and CSO

Executive Director
5,000 +1.7%
4.97
US$24,830 		5,000 +1.7% 4.97 US$24,830
2019-08-12 2019-08-09 B Purchase Fowler John Franklin

CEO

Executive Director
750 +0.3%
5.01
US$3,761 		750 +0.3% 5.01 US$3,761
2019-08-12 2019-08-09 B Purchase Fowler John Franklin

CEO

Executive Director
500 +0.2%
5.26
US$2,628 		500 +0.2% 5.26 US$2,628
2019-07-26 2019-07-26 B Purchase
0.8
Belsky Marc

CFO
56 +12.6%
5.80
US$325 		56 +12.6% 5.80 US$325
2019-07-26 2019-07-25 B Purchase
0.8
Belsky Marc

CFO
444 +inf%
5.65
US$2,510 		444 +inf% 5.65 US$2,510
2019-07-23 2019-07-22 B Purchase
1.7
Economides Vassiliki

SVP, Strategy & External Aff.
431 +inf%
5.82
US$2,509 		431 +inf% 5.82 US$2,509
2021-03-29 2019-05-30 PP Planned purchase
1.7
Economides Vassiliki

SVP, Strategy & External Aff.

Officer
750 +7.1%
10.19
US$7,642 		750 +7.1% 10.19 US$7,642
2018-06-28 2018-06-25 B Purchase BAY CITY CAPITAL LLC Large shareholder
150,000 +31.8%
15.00
US$2,250,000 		150,000 +31.8% 15.00 US$2,250,000
2018-06-27 2018-06-25 B Purchase Cormorant Asset Management, LP Large shareholder
250,000 +18.9%
15.00
US$3,750,000 		250,000 +18.9% 15.00 US$3,750,000
2018-06-27 2018-06-25 B Purchase Morningside Venture Investments Ltd Large shareholder
250,000 +12.1%
15.00
US$3,750,000 		250,000 +12.1% 15.00 US$3,750,000
2018-06-27 2018-06-25 B Purchase BERGER FRANKLIN M
50,000 +9.7%
15.00
US$750,000 		50,000 +9.7% 15.00 US$750,000
Explore more

More insider trading research around Kezar Life Sciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America